This is well and truly back on the radar but it still has a bit more to do to prove itself for a medium term position so I wouldn't suggest being too complacent just yet.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025